Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Net sales increased due to growth at Takara Shuzo and the Takara Shuzo International Group. Operating income declined because of higher transportation costs, personnel expenses and administrative expenses. Net income was affected by gains on the sale of noncurrent assets and investment securities, as well as the recognition of costs related to the tender offer and business structural reform costs.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥103,207 million (YoY +10.6%) |
| Operating profit | ¥2,949 million (YoY -14.7%) |
| Ordinary income | ¥3,157 million (YoY -9.1%) |
| Profit attributable to owners of the parent | ¥3,630 million (YoY -12.4%) |
| Net income per share | ¥18.87 |
| Equity ratio | End of the current fiscal period 46 / End of previous period 50.5 |
| Total assets | ¥535,691 million |
| Net assets | ¥257,626 million |
| Full-year earnings forecast | Net Sales Not disclosed / Operating profit Not disclosed / Ordinary income Not disclosed / Net income Not disclosed / Remarks Currently under review. Scheduled for disclosure when the company announces its second-quarter results on 10 November 2026. |
| Revision to Earnings Forecast | Net Sales ¥205,000 million → ¥210,870 million（+2.9%） / Operating profit ¥8,800 million → ¥13,112 million（+49.0%） / Ordinary income ¥7,800 million → ¥12,764 million（+63.6%） / Interim net income attributable to owners of the parent ¥5,900 million → ¥11,682 million（+98.0%） |
| Annual Dividend Forecast | ¥31 → ¥31（0.0%） |
| Segment revenue | Takara Shuzo ¥30,245 million (YoY +2.5%), Takara Shuzo International Group ¥60,334 million (YoY +17.3%), Takara Bio Group ¥9,204 million (YoY -0.7%) |
| Segment profit | Takara Shuzo ¥1,468 million (YoY +47.5%), Takara Shuzo International Group ¥3,937 million (YoY +7.8%), Takara Bio Group ¥-3,384 million |
| Depreciation and amortization | ¥3,163 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥886 million, Gain on sale of investment securities ¥1,746 million / Extraordinary loss Business-Structure Reform Costs ¥1,655 million, Costs related to the tender offer ¥804 million, Other regions ¥130 million |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | 0 additions and 0 exclusions. No material changes. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No (no eligible attendees) |
| Issued Shares at Period-End | 197,252,043 Shares |
| Treasury Shares at Period-End | 5,807,689 Shares |
| Factors Behind Changes in Business Performance | Net sales increased due to growth at Takara Shuzo and the Takara Shuzo International Group. Operating income declined because of higher transportation costs, personnel expenses and administrative expenses. Net income was affected by gains on the sale of noncurrent assets and investment securities, as well as the recognition of costs related to the tender offer and business structural reform costs. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales increased due to growth at Takara Shuzo and the Takara Shuzo International Group, while operating income declined because of higher transportation costs, personnel expenses and administrative expenses. Net income was affected by gains on the sale of noncurrent assets and investment securities, as well as the recognition of costs related to the tender offer and business structural reform costs associated with Takara Bio's voluntary retirement program. The upward revision to the second-quarter forecast reflects the effects of price revisions, reciprocal tariff refunds, foreign exchange movements and more efficient use of selling, general and administrative expenses.